4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000062
Chief Medical Officer sold 231,716 shares at an average $12.92 ($2,994,401)
- Chief Medical Officer acquired 231,716 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2023-08-10 | Option exercise | +74,625 | $0.54 | $40,298 | 74,625 | D |
| Rodman David Malcom Chief Medical Officer | 2023-08-10 | Sale | −74,625 | $13.16 | $982,065 | 0 | D |
| Rodman David Malcom Chief Medical Officer | 2023-08-11 | Option exercise | +80,909 | $0.54 | $43,691 | 80,909 | D |
| Rodman David Malcom Chief Medical Officer | 2023-08-11 | Sale | −80,909 | $12.81 | $1,036,444 | 0 | D |
| Rodman David Malcom Chief Medical Officer | 2023-08-11 | Option exercise | +76,182 | $1.08 | $82,277 | 76,182 | D |
| Rodman David Malcom Chief Medical Officer | 2023-08-11 | Sale | −76,182 | $12.81 | $975,891 | 0 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2023-08-10 | Option exercise · Stock Option | −74,625 | 166,202 | D | ||
| Rodman David Malcom Chief Medical Officer | 2023-08-11 | Option exercise · Stock Option | −80,909 | 85,293 | D | ||
| Rodman David Malcom Chief Medical Officer | 2023-08-11 | Option exercise · Stock Option | −76,182 | 228,548 | D | ||
| Open-market sales · 231,716 sh · avg $12.92 · $2,994,401 | |||||||
Loading xslF345X05/wf-form4_169179547763057.xml…